SBIR firms in the news
- Alume Biosciences Completes $5.5M Series a Financing: Robust Angel Investor-led Series a expected to fully fund Phase 1/2 clinical study for lead surgical nerve-targeting candidate
- Team develops rapid SARS-CoV-2 test based on new plasmonic-fluor biolabeling technology
- Daxor Corporation's BVA-100® Test Used to Guide Treatment in COVID-19 Patient
- NIH activates new funding vehicle for COVID-19 R&D, other measures seek more information
- Daxor Corporation Announces Engagement with Hospitals and Government for Use of the Blood Volume Analyzer (BVA-100®) to Stem COVID-19 Deaths
- Alume Biosciences Completes $5.5M Series a Financing: Robust Angel Investor-led Series a expected to fully fund Phase 1/2 clinical study for lead surgical nerve-targeting candidate
- Team develops rapid SARS-CoV-2 test based on new plasmonic-fluor biolabeling technology
- Daxor Corporation's BVA-100® Test Used to Guide Treatment in COVID-19 Patient
- NIH activates new funding vehicle for COVID-19 R&D, other measures seek more information
- Daxor Corporation Announces Engagement with Hospitals and Government for Use of the Blood Volume Analyzer (BVA-100®) to Stem COVID-19 Deaths
Processing...